Publication | Closed Access

Patterns of Infection in Patients With Myelodysplastic Syndromes and Acute Myeloid Leukemia Receiving Azacitidine as Salvage Therapy. Implications for Primary Antifungal Prophylaxis

Hematological MalignancyAntibioticsAntifungal AgentsMyeloid NeoplasiaPathologyPrimary Antifungal ProphylaxisAntimicrobial ChemotherapyInfection ControlMedicineClinical MicrobiologyAntimicrobial ResistanceMyelodysplastic SyndromesSalvage Therapy